Miriam E. Tucker

News

Endoscopic Procedure Shows Promise in Type 2 Diabetes Care

Author:: Miriam E. Tucker

Publish date: May 13, 2025

The outpatient technique is based on pulsed electrical fields, or electroporation, which do not use heat.

News

Commission Issues ‘Radical Overhaul’ of Obesity Diagnosis

Author:: Miriam E. Tucker

Publish date: January 15, 2025

Clinical or preclinical obesity diagnosis is based on waist circumference, BMI, symptoms, and functional limitations.

News

Obesity Drug Zepbound Approved for Obstructive Sleep Apnea

Author:: Miriam E. Tucker

Publish date: December 24, 2024

The once-weekly injectable is the first-ever drug treatment for OSA.

News

Post-Exertional Malaise in Fatiguing Diseases: What to Know to Avoid Harmful Exercise

Author:: Miriam E. Tucker

Publish date: December 23, 2024

Measures of pain, fatigue, sleep, patient global assessment, activity score, polysymptomatic distress, disability, depression, anxiety, and other f...

News

Inhaled Insulin Benefits Kids With Diabetes, Too

Author:: Miriam E. Tucker

Publish date: December 18, 2024

Mannkind announced 6-month results from its phase 3 study of inhaled human insulin in patients aged 4-17.

News

CGM Use, GLP-1s, Drinking Water Key of 2025 ADA Standards

Author:: Miriam E. Tucker

Publish date: December 11, 2024

A new recommendation strongly advises drinking water instead of nutritive or nonnutritive sweetened beverages.

News

ADA Advises Against Using Compounded GLP-1 RA Medications

Author:: Miriam E. Tucker

Publish date: December 5, 2024

The new ADA statement pertains to the unapproved, unregulated versions that have emerged as the demand for these medications for weight loss increa...

News

Drugs Targeting Osteoarthritis Pain: What’s in Development?

Author:: Miriam E. Tucker

Publish date: December 4, 2024

While much of the field focuses on disease modification, some agents are in development specifically to reduce OA pain.&nbs...

News

Kidney, Cardiovascular Benefits Seen With GLP-1 RA Drugs in SLE, Lupus Nephritis

Author:: Miriam E. Tucker

Publish date: November 26, 2024

The glucose-lowering and weight-reducing drug class appears to benefit the heart and kidneys in people with lupus and lupus...

News

RA Assessment Via Automated Ultrasound Scanner With AI Saves Time, Performs as Well as Rheumatologists

Author:: Miriam E. Tucker

Publish date: November 25, 2024

Danish startup company’s combined hand scanner and artificial intelligence analyzer perform similarly to human rheumatologi...

News

Cancer Mortality Not Higher for Patients With Autoimmune Disease on Checkpoint Inhibitors

Author:: Miriam E. Tucker

Publish date: November 21, 2024

Large database study finds no increase in mortality, although other endpoints haven’t yet been reported, and the findings might not apply to those ...

News

Oral Semaglutide 25-mg Dose May Provide Most Benefit

Author:: Miriam E. Tucker

Publish date: November 20, 2024

News

Holding RA, SpA Drugs Did Not Improve Antibody Response to COVID Vaccine

Author:: Miriam E. Tucker

Publish date: November 19, 2024

Most patients with rheumatoid arthritis or spondyloarthritis had significant antibody responses to COVID vaccine boosters, whether or not their imm...

News

Gout and SGLT2 Inhibitors: Evidence Points to Reduced Need for ULT, Flare Drugs

Author:: Miriam E. Tucker

Publish date: November 19, 2024

Real-world data show reduction in use of urate-lowering therapy among people with type 2 diabetes using SGLT2 inhibitors.

News

First Phase 3 Drug Trial in IgG4-Related Disease Has Success

Author:: Miriam E. Tucker

Publish date: November 18, 2024

Dramatic study results point to the potential for a steroid-sparing option for patients with the underrecognized multiorgan condition.